Who Would Have Thought: How Zyn and Nicotine Pouches Became Silicon Valley’s Unlikely Productivity Obsession

In the heart of Silicon Valley, where kombucha taps, standing desks, and cold plunges once defined the wellness culture, a new staple has quietly taken over: tiny white pouches of nicotine tucked under the lip.

Who Would Have Thought: How Zyn and Nicotine Pouches Became Silicon Valley’s Unlikely Productivity Obsession Zyn — and its growing list of competitors like Lucy and Sesh — has gone from a niche Swedish snus alternative to an unofficial (and sometimes fully official) office perk. Who would have guessed that a product once dismissed as a “degenerate” habit would become as commonplace in tech as free LaCroix?

It’s not just tolerated. In many companies, it’s actively supported.

Take Palantir Technologies. In its Washington, D.C. office, branded vending machines from nicotine startups Lucy and Sesh dispense flavored pouches for free to employees and guests over 21. The company itself foots the bill.

According to reports, the machines sit alongside other workplace amenities — effectively turning nicotine into the modern equivalent of the 19th-century smoke break. Some employees even report finding pouches near coffee stations, right where you’d grab your afternoon espresso.

And Palantir isn’t alone. Smaller startups have gone even further. At Austin-based AI healthcare company Hello Patient, founder Alex Cohen installed a dedicated “nic fridge” in the office kitchen after noticing Zyn tins on engineers’ desks. The engineers were laser-focused during marathon coding sessions; Cohen tried it himself, got hooked, and made it a company perk. In some early-stage startups, the joke going around is that there’s no corporate lunch budget — but there is unlimited free nicotine pouches.

Why Tech Embraced It

The reason is brutally pragmatic, and it’s the same one that drives every other biohacking trend in the Valley: performance.

Who Would Have Thought: How Zyn and Nicotine Pouches Became Silicon Valley’s Unlikely Productivity Obsession Moderate doses of nicotine are prized for delivering a clean, jitter-free boost. Users describe it as the perfect mix of stimulation and calm — sharpening focus, crushing anxiety, and delivering that elusive “clear head” state during 12- to 15-hour workdays. For founders and engineers battling ADHD or the constant pressure of AI-era deadlines, it’s become a psychological edge.

Entrepreneur Garrett Campbell, a 26-year-old software founder, told WIRED he keeps a 6-mg “cool mint” pouch under his lip almost constantly. “I just view it as, does this help me make more money and work more efficiently or not?” he said. “It’s a really weird blend of being stimulating and good for focus, but it’s also relaxing. It keeps you in this cool, calm, and collected feeling.”

Flow-state coach Cory Firth echoed the sentiment: he cycles on and off the pouches but admits he’s “addicted to the amount of output” they enable. Even philosopher Nick Bostrom has experimented with nicotine for nootropic benefits, preferring a pure form but acknowledging the appeal of the “machine-like” focus it provides.

Employers aren’t blind to this. In a hyper-competitive industry where output is everything, anything that keeps talent “zipped up and ready to work” (as one Palantir-related report put it) gets a green light. It’s cheaper than another round of free lunches, and — unlike Adderall scripts or endless espresso shots — it doesn’t come with the same stigma or HR headaches.

From “Harmful Habit” to Valley Status Symbol

Zyn, now owned by Philip Morris International, has ridden this wave perfectly. The company shipped 794 million cans in the U.S. last year alone — a 37% jump. What was once marketed as a discreet smoking-cessation tool for adults has been rebranded in Silicon Valley as a clean, smokeless, odorless “nootropic.” No tar, no smoke, no lingering vape cloud — just a quick hit of focus between stand-ups.

Who Would Have Thought: How Zyn and Nicotine Pouches Became Silicon Valley’s Unlikely Productivity Obsession Tech bros have turned it into a cultural badge. You’ll see the telltale bulge under the lip during pitch meetings, late-night debugging sessions, and even on X (formerly Twitter) where founders casually flex their latest flavor rotation. It fits perfectly into the existing biohacking ethos: cold plunges for recovery, nootropics for cognition, and now nicotine pouches for that extra gear.

Of course, the trade-offs are real. Doctors warn about addiction, gum recession, and the loss of autonomy that comes with any stimulant. Bryan Johnson, the extreme biohacker himself, has publicly cautioned against it: “Nicotine is not some harmless productivity hack… the trade-off is addiction, and you lose your autonomy.”

But in a culture that already runs on espresso, energy drinks, and the occasional microdose, the calculus is simple: if it helps ship product faster, many are willing to roll the dice.

Zyn (and the broader nicotine-pouch industry) didn’t just ride the wave — it helped create it. What started as a quirky European import has been polished, flavored, and optimized into one of the Valley’s most effective “useful” vices. Harmful habit with unpleasant side effects? Sure. But in Silicon Valley in 2026, it’s also the perk that keeps the machines running.

And if the vending machines start showing up next to the kombucha taps in more offices, don’t be surprised.

The future of work, apparently, tastes like cool mint.